Making Hepatitis C Diagnosis Accessible Via Point-of-Care HCV Viral Load Assays
A new study shows the benefits of using a quick clinic-based diagnostic test for hepatitis C virus infection over a standard lab-based test.
Read MorePosted by Andy Lundin | Jan 27, 2023 | Infectious Diseases, Point-of-Care |
A new study shows the benefits of using a quick clinic-based diagnostic test for hepatitis C virus infection over a standard lab-based test.
Read MorePosted by Andy Lundin | Jan 18, 2023 | Diagnostic Technologies |
ALiA BioTech is ready to deploy a rapid diagnostic platform that can conduct multiplex testing in a single biochip within 15 minutes.
Read MorePosted by Andy Lundin | Jan 17, 2023 | Diagnostic Technologies |
AXIM Biotechnologies filed a provisional patent application on a new test designed to measure the neutralizing antibodies against fentanyl.
Read MorePosted by Andy Lundin | Jan 16, 2023 | Flu & Respiratory Infections, Molecular Diagnostic Analyzers |
A new method of rapid, yet quantitative and specific point-of-care detection of antibodies uses an electrochemical cell-free biosensor.
Read MorePosted by Andy Lundin | Jan 13, 2023 | Covid 19, Rapid Assays |
eMed partnered with NIH and ASPR to provide at-home treatment based on telehealth evaluations and rapid COVID test results.
Read More